JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: DLin-KC2-DMA is novel ionizable and cationic lipid useful for siRNA delivery. DLin-KC2-DMA was formulated and characterized in SNALP and demonstrated to have in vivo activity at siRNA doses as low as 0.01 mg/kg in rodents and 0.1 mg/kg in nonhuman primates.
References: Delivery of RNAi therapeutics: work in progress. Expert Rev Med Devices. 2013 Nov; 10(6):781-811.; Design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA.Nanomedicine. 2017 May; 13(4):1377-1387. doi: 10.1016/j.nano.2016.12.014. Epub2016 Dec 28. PubMed PMID: 28038954.
Related CAS #: 1224373-32-3 (S-isomer) 1224373-36-7 (R-isomer) 1190197-97-7
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Recommend by mail
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!